Oyster Point Pharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Oyster Point Pharma, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $11.55 per share as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2022-11-10
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $11.55.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $11210.00.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $10840.00.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $9.36.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2022-09-30 | $11.55 10-Q · filed 2022-11-10 |
| 2022-06-30 | $11210.00 10-Q · filed 2022-08-11 |
| 2022-03-31 | $10840.00 10-Q · filed 2022-05-05 |
| 2021-12-31 | $9.36 10-K · filed 2022-02-24 |
| 2021-09-30 | $7150.00 10-Q · filed 2021-11-04 |
| 2021-06-30 | $6550.00 10-Q · filed 2021-08-05 |
| 2021-03-31 | $5930.00 10-Q · filed 2021-05-06 |
| 2020-12-31 | $3.46 10-K · filed 2021-02-18 |
| 2020-09-30 | $3160.00 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2290.00 10-Q · filed 2020-08-05 |
| 2020-03-31 | $2180.00 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.10 10-K · filed 2020-02-27 |